Mostrar o rexistro simple do ítem

dc.contributor.authorMateos, Jesús
dc.contributor.authorArufe, M.C.
dc.contributor.authorFernández-Pernas, Pablo
dc.contributor.authorFafián Labora, Juan Antonio
dc.contributor.authorBlanco García, Francisco J
dc.date2014
dc.date.accessioned2017-04-26T07:46:25Z
dc.date.available2017-04-26T07:46:25Z
dc.date.issued2014-02-07
dc.identifier.citationMateos J, Pernas PF, Labora JF, Blanco F, Arufe MD. Proteomic Applications in the Study of Human Mesenchymal Stem Cells. Proteomes. 2014 Feb 7;2(1):53-71.es_ES
dc.identifier.issn2227-7382
dc.identifier.urihttp://hdl.handle.net/2183/18446
dc.description.abstractMesenchymal stem cells (MSCs) are undifferentiated cells with an unlimited capacity for self-renewal and able to differentiate towards specific lineages under appropriate conditions. MSCs are, a priori, a good target for cell therapy and clinical trials as an alternative to embryonic stem cells, avoiding ethical problems and the chance for malignant transformation in the host. However, regarding MSCs, several biological implications must be solved before their application in cell therapy, such as safe ex vivo expansion and manipulation to obtain an extensive cell quantity amplification number for use in the host without risk accumulation of genetic and epigenetic abnormalities. Cell surface markers for direct characterization of MSCs remain unknown, and the precise molecular mechanisms whereby growth factors stimulate their differentiation are still missing. In the last decade, quantitative proteomics has emerged as a promising set of techniques to address these questions, the answers to which will determine whether MSCs retain their potential for use in cell therapy. Proteomics provides tools to globally analyze cellular activity at the protein level. This proteomic profiling allows the elucidation of connections between broad cellular pathways and molecules that were previously impossible to determine using only traditional biochemical analysis. However; thus far, the results obtained must be orthogonally validated with other approaches. This review will focus on how these techniques have been applied in the evaluation of MSCs for their future applications in safe therapies.es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MICINN/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/PI11%2F02799/ES/Combinación de terapias celulares para la reparación de lesiones de cartílagoes_ES
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institutees_ES
dc.relation.urihttp://dx.doi.org/10.3390/proteomes2010053es_ES
dc.rightsCreative Commons Attribution 3.0 International License (CC-BY 3.0)es_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/
dc.subjectMesenchymal stem celles_ES
dc.subjectProteomic analysises_ES
dc.subjectCharacterizationes_ES
dc.subjectDifferentiationes_ES
dc.titleProteomic applications in the study of human mesenchymal stem cellses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/openAccesses_ES
UDC.journalTitleProteomeses_ES
UDC.volume2es_ES
UDC.issue1es_ES
UDC.startPage53es_ES
UDC.endPage71es_ES


Ficheiros no ítem

Thumbnail
Thumbnail

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem